| scholarly article | Q13442814 |
| P2093 | author name string | Hua Zhang | |
| Ping Xie | |||
| Yuan Zhang | |||
| Dongfeng Gu | |||
| Cam Patterson | |||
| Huihua Li | |||
| Mingpeng She | |||
| Yongna Fan | |||
| P2860 | cites work | Cooperation of molecular chaperones with the ubiquitin/proteasome system | Q35967558 |
| Phosphorylated tau and the neurodegenerative foldopathies | Q35992172 | ||
| Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins | Q36088932 | ||
| Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex | Q40177208 | ||
| Glycogen synthase kinase 3beta inhibits myocardin-dependent transcription and hypertrophy induction through site-specific phosphorylation | Q40377590 | ||
| The chaperone-associated ubiquitin ligase CHIP is able to target p53 for proteasomal degradation | Q40418287 | ||
| SUMO-1 modification activated GATA4-dependent cardiogenic gene activity | Q40520891 | ||
| Pharmacology of the mouse-isolated cerebral artery | Q45068681 | ||
| Chaperone-dependent stabilization and degradation of p53 mutants | Q46788559 | ||
| Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. | Q54596085 | ||
| The RhoA/Rho kinase pathway regulates nuclear localization of serum response factor | Q73035716 | ||
| Role of tyrosine kinases in extracellular matrix-mediated modulation of arterial smooth muscle cell phenotype | Q73832899 | ||
| Nonlinearity in intracochlear pressure | Q79302481 | ||
| Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions | Q22010047 | ||
| The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins | Q24290709 | ||
| Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype | Q24292785 | ||
| Phenotypic modulation of smooth muscle cells through interaction of Foxo4 and myocardin | Q24311484 | ||
| The cochaperone HspBP1 inhibits the CHIP ubiquitin ligase and stimulates the maturation of the cystic fibrosis transmembrane conductance regulator | Q24562651 | ||
| The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro | Q24608829 | ||
| Akt and CHIP coregulate tau degradation through coordinated interactions | Q24656202 | ||
| Myocardin is a master regulator of smooth muscle gene expression | Q24680761 | ||
| SCF(beta-TRCP) and phosphorylation dependent ubiquitinationof I kappa B alpha catalyzed by Ubc3 and Ubc4 | Q28142245 | ||
| CHIP-Hsc70 Complex Ubiquitinates Phosphorylated Tau and Enhances Cell Survival | Q28183470 | ||
| ErbB2 degradation mediated by the co-chaperone protein CHIP | Q28208008 | ||
| CHIP is a U-box-dependent E3 ubiquitin ligase: identification of Hsc70 as a target for ubiquitylation | Q28216253 | ||
| Retrograde transport of the glucocorticoid receptor in neurites requires dynamic assembly of complexes with the protein chaperone hsp90 and is linked to the CHIP component of the machinery for proteasomal degradation | Q28252956 | ||
| Myocardin regulates expression of contractile genes in smooth muscle cells and is required for closure of the ductus arteriosus in mice | Q28506846 | ||
| PIAS1 activates the expression of smooth muscle cell differentiation marker genes by interacting with serum response factor and class I basic helix-loop-helix proteins. | Q28569320 | ||
| Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor | Q28587239 | ||
| Molecular regulation of vascular smooth muscle cell differentiation in development and disease | Q29615194 | ||
| Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization | Q30306237 | ||
| Myocardin and Prx1 contribute to angiotensin II-induced expression of smooth muscle alpha-actin | Q30312218 | ||
| 5' CArG degeneracy in smooth muscle alpha-actin is required for injury-induced gene suppression in vivo | Q30435837 | ||
| Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells | Q30441514 | ||
| C-terminus of heat shock protein 70-interacting protein facilitates degradation of apoptosis signal-regulating kinase 1 and inhibits apoptosis signal-regulating kinase 1-dependent apoptosis | Q33899695 | ||
| Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. | Q34304925 | ||
| The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins | Q35629026 | ||
| Myocardin sumoylation transactivates cardiogenic genes in pluripotent 10T1/2 fibroblasts | Q35642137 | ||
| Control of smooth muscle development by the myocardin family of transcriptional coactivators | Q35893541 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell differentiation | Q210861 |
| P304 | page(s) | 2398-2408 | |
| P577 | publication date | 2009-02-23 | |
| P1433 | published in | Molecular and Cellular Biology | Q3319478 |
| P1476 | title | CHIP represses myocardin-induced smooth muscle cell differentiation via ubiquitin-mediated proteasomal degradation | |
| P478 | volume | 29 |
| Q28078724 | A Decade of Boon or Burden: What Has the CHIP Ever Done for Cellular Protein Quality Control Mechanism Implicated in Neurodegeneration and Aging? |
| Q52568542 | Anisomycin prevents OGD-induced necroptosis by regulating the E3 ligase CHIP. |
| Q51647453 | Atrogin-1 Increases Smooth Muscle Contractility Through Myocardin Degradation. |
| Q35036537 | Bortezomib, a proteasome inhibitor, attenuates angiotensin II-induced hypertension and aortic remodeling in rats |
| Q37339007 | C terminus of Hsc70-interacting protein promotes smooth muscle cell proliferation and survival through ubiquitin-mediated degradation of FoxO1. |
| Q35561105 | Carboxyl terminus of HSC70-interacting protein (CHIP) down-regulates NF-κB-inducing kinase (NIK) and suppresses NIK-induced liver injury |
| Q51539199 | Carboxyl terminus of heat shock protein 70-interacting protein inhibits angiotensin II-induced cardiac remodeling. |
| Q33888579 | Co-activation of nuclear factor-κB and myocardin/serum response factor conveys the hypertrophy signal of high insulin levels in cardiac myoblasts |
| Q35659471 | Dysfunction of the ubiquitin-proteasome system in atherosclerotic cardiovascular disease |
| Q40963450 | GSK3 as a Sensor Determining Cell Fate in the Brain |
| Q42121187 | How do your contacts (or their absence) shape your fate? |
| Q89736816 | IKK Epsilon Deficiency Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Mice by Inhibiting Inflammation, Oxidative Stress, and Apoptosis |
| Q90116251 | Inactivation of carboxyl terminus of Hsc70-interacting protein prevents hypoxia-induced pulmonary arterial smooth muscle cells proliferation by reducing intracellular Ca2+ concentration |
| Q36217025 | Inhibition of Proteasome Activity by Low-dose Bortezomib Attenuates Angiotensin II-induced Abdominal Aortic Aneurysm in Apo E(-/-) Mice |
| Q37371749 | Mechanical regulation of the proangiogenic factor CCN1/CYR61 gene requires the combined activities of MRTF-A and CREB-binding protein histone acetyltransferase. |
| Q33782403 | Modulation of myocardin function by the ubiquitin E3 ligase UBR5. |
| Q38368573 | Myocardin in biology and disease |
| Q41714511 | Nuclear Import Mechanism for Myocardin Family Members and Their Correlation with Vascular Smooth Muscle Cell Phenotype |
| Q33554513 | On to the road to degradation: atherosclerosis and the proteasome |
| Q39176194 | Opposite roles of myocardin and atrogin-1 in L6 myoblast differentiation |
| Q39171320 | Phosphorylation acts positively and negatively to regulate MRTF-A subcellular localisation and activity |
| Q37997409 | Physiological and pathological role of the ubiquitin-proteasome system in the vascular smooth muscle cell |
| Q38858325 | Potential Role of Glycogen Synthase Kinase-3β in Regulation of Myocardin Activity in Human Vascular Smooth Muscle Cells |
| Q37024066 | Protection against doxorubicin-induced myocardial dysfunction in mice by cardiac-specific expression of carboxyl terminus of hsp70-interacting protein |
| Q38849785 | Protein kinase Cα inhibits myocardin-induced cardiomyocyte hypertrophy through the promotion of myocardin phosphorylation |
| Q35739011 | Receptor for Advanced Glycation End-Products Signaling Interferes with the Vascular Smooth Muscle Cell Contractile Phenotype and Function |
| Q36125400 | Requirement of miR-9-dependent regulation of Myocd in PASMCs phenotypic modulation and proliferation induced by hepatopulmonary syndrome rat serum |
| Q35925825 | STAT3 Protein Regulates Vascular Smooth Muscle Cell Phenotypic Switch by Interaction with Myocardin |
| Q37628822 | Seek and destroy: the ubiquitin----proteasome system in cardiac disease. |
| Q33679929 | Sent to destroy: the ubiquitin proteasome system regulates cell signaling and protein quality control in cardiovascular development and disease |
| Q37890184 | Signaling mechanisms that regulate smooth muscle cell differentiation |
| Q47631097 | Targeting the ubiquitin-proteasome system for cancer treatment: discovering novel inhibitors from nature and drug repurposing |
| Q30268527 | The E3 Ligase CHIP Mediates p21 Degradation to Maintain Radioresistance |
| Q38164901 | The role of ubiquitin ligases in cardiac disease. |
| Q27021582 | The ubiquitin-proteasome system and cardiovascular disease |
| Q39500140 | Ubiquitin ligase CHIP induces TRAF2 proteasomal degradation and NF-κB inactivation to regulate breast cancer cell invasion |
| Q39454012 | β-catenin and Smad3 regulate the activity and stability of myocardin-related transcription factor during epithelial-myofibroblast transition |
Search more.